BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1704666)

  • 21. Clinical and biological activity of the interferons in hematologic malignancies.
    Gutterman JU
    Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hairy cell leukemia: clinical course, prognostic factors and therapy].
    Hofmann V
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):427-9. PubMed ID: 2421385
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
    Rossi E; Gualandi F; Lamparelli T; Repetto M; Nocera A; Spriano M; Occhini D; Ruggeri C; Vimercati R; Damasio EE
    J Exp Pathol; 1987; 3(4):593-601. PubMed ID: 3502652
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 25. Hairy cell leukemia: the Italian Cooperative Group experience.
    Federico M; Frassoldati A; Lamparelli T; Dini E; Resegotti L; Damasio EE
    Leukemia; 1992 Nov; 6 Suppl 4():147-8. PubMed ID: 1279328
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological effects of interferons and their role in onco-hematological conditions.
    Agostini C; Pizzolo G; Semenzato G
    Allergol Immunopathol (Madr); 1991; 19(5):187-93. PubMed ID: 1725840
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of hairy cell leukemia with human leukocyte interferons].
    Ikkala E; Ala-Harja K; Almqvist A; Hallman H; Honkanen T; Pelliniemi TT; Timonen T
    Duodecim; 1987; 103(16):977-80. PubMed ID: 3454328
    [No Abstract]   [Full Text] [Related]  

  • 28. [Various aspects and results of therapy with interferon].
    Niederle N
    Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced bone marrow colony growth in hairy-cell leukemia before and after interferon-alpha treatment. Possible inhibitory role of a serological factor.
    Lauria F; Bagnara GP; Guarini A; Catani L; Gaggioli L; Gugliotta L; Raspadori D; Macchi S; Zauli G; Zinzani PL
    Haematologica; 1988; 73(3):191-4. PubMed ID: 3139514
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
    Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon.
    Hagberg H; Hassan I; Glimelius B; Gronowitz S; Källander C; Martinsson U; Sundström C
    Haematologica; 1988; 73(5):365-9. PubMed ID: 3143633
    [No Abstract]   [Full Text] [Related]  

  • 32. Toward defining an optimal therapy for hairy cell leukemia.
    Horning S
    J Natl Cancer Inst; 1989 Aug; 81(15):1120-1. PubMed ID: 2473213
    [No Abstract]   [Full Text] [Related]  

  • 33. Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses.
    Habermann TM; Rai K
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():18-20. PubMed ID: 21599602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interferon therapy in hematologic neoplasms].
    Schwarzinger I; Bettelheim P; Lechner K
    Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
    Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hairy cell leukemia with ultrastructural finding of 'tubuloreticular inclusions' in hairy cells: a possible marker of a virus-induced disease?
    Mantovani G; Santa Cruz G; Piso A; Arangino V; Balestrieri A; Del Giacco GS
    J Submicrosc Cytol; 1986 Jul; 18(3):617-24. PubMed ID: 3746974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenectomy for the treatment of hairy-cell leukemia.
    Eldar S; Kemeny MM; Benfield JR
    Surg Gynecol Obstet; 1982 Dec; 155(6):829-32. PubMed ID: 7147163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon's track record: good in hairy-cell leukemia, fair in other hematologic cancers, poor in solid tumors.
    Merz B
    JAMA; 1986 Sep; 256(10):1242-4. PubMed ID: 2427752
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
    Samuels BL; Golomb HM; Brownstein BH
    Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.